Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 94

Sort by

Sort Order Select

Journal Articles

Impact of a grant program to spur advances in sickle cell disease research

Sindy N. Escobar Alvarez, Elizabeth R. Myers

Blood Adv (2021) 5 (19): 3855–3861.

https://doi.org/10.1182/bloodadvances.2021005709

Published: 2021

Includes: Supplemental data

Journal Articles

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation

Julie Kanter, Robert I. Liem, Françoise Bernaudin, Javier Bolaños-Meade, Courtney D. Fitzhugh, Jane S. Hankins, M. Hassan Murad, Julie A. Panepinto, Damiano Rondelli, Shalini Shenoy, John Wagner, Mark C. Walters, Teonna Woolford, Joerg J. Meerpohl, John Tisdale

Blood Adv (2021) 5 (18): 3668–3689.

https://doi.org/10.1182/bloodadvances.2021004394

Published: 2021

Includes: Supplemental data

Journal Articles

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease

Lana Mucalo, Amanda M. Brandow, Mahua Dasgupta, Sadie F. Mason, Pippa M. Simpson, Ashima Singh, Bradley W. Taylor, Katherine J. Woods, Fouza I. Yusuf, Julie A. Panepinto

Blood Adv (2021) 5 (13): 2717–2724.

https://doi.org/10.1182/bloodadvances.2021004288

Published: 2021

Includes: Supplemental data

Journal Articles

Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage

Stacey Uter, Hyun Hyung An, Grace E. Linder, Stephan Kadauke, Deborah Sesok-Pizzini, Haewon C. Kim, David F. Friedman, Stella T. Chou

Blood Adv (2021) 5 (12): 2586–2592.

https://doi.org/10.1182/bloodadvances.2021004395

Published: 2021

Includes: Supplemental data

Journal Articles

Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease

Alexis Leonard, Akshay Sharma, Naoya Uchida, David Stroncek, Sandhya R. Panch, Kamille West, Eoghan Molloy, Thomas E. Hughes, Sara Hauffe, Tiffani Taylor, Courtney Fitzhugh, Jane S. Hankins, Megan Wilson, Shengdar Q. Tsai, Mitchell J. Weiss, Matthew Hsieh, John F. Tisdale

Blood Adv (2021) 5 (9): 2403–2411.

https://doi.org/10.1182/bloodadvances.2021004232

Published: 2021

Includes: Supplemental data

Journal Articles

FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice

Archana Shrestha, Mengna Chi, Kimberly Wagner, Astha Malik, Jennifer Korpik, Adam Drake, Keertik Fulzele, Sylvie Guichard, Punam Malik

Blood Adv (2021) 5 (9): 2385–2390.

https://doi.org/10.1182/bloodadvances.2020003604

Published: 2021

Includes: Supplemental data

Journal Articles

Characterization and statistical modeling of glycosylation changes in sickle cell disease

Heather E. Ashwood, Christopher Ashwood, Anna P. Schmidt, Rebekah L. Gundry, Karin M. Hoffmeister, Waseem Q. Anani

Blood Adv (2021) 5 (5): 1463–1473.

https://doi.org/10.1182/bloodadvances.2020003376

Published: 2021

Includes: Supplemental data

Journal Articles

MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease

Melanie Demers, Sarah Sturtevant, Kevin R. Guertin, Dipti Gupta, Kunal Desai, Benjamin F. Vieira, Wenjing Li, Alexandra Hicks, Ayman Ismail, Bronner P. Gonçalves, Giuseppe Di Caprio, Ethan Schonbrun, Scott Hansen, Faik N. Musayev, Martin K. Safo, David K. Wood, John M. Higgins, David R. Light

Blood Adv (2021) 5 (5): 1388–1402.

https://doi.org/10.1182/bloodadvances.2020003670

Published: 2021

Includes: Supplemental data

Journal Articles

Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients

Marie Tamagne, Sadaf Pakdaman, Pablo Bartolucci, Anoosha Habibi, Frédéric Galactéros, France Pirenne, Benoît Vingert

Blood Adv (2021) 5 (5): 1278–1282.

https://doi.org/10.1182/bloodadvances.2020003537

Published: 2021

Includes: Supplemental data

Journal Articles

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Suhag Parikh, Joel A. Brochstein, Einat Galamidi, Aurélie Schwarzbach, Joanne Kurtzberg

Blood Adv (2021) 5 (3): 843–852.

https://doi.org/10.1182/bloodadvances.2020003248

Published: 2021

Includes: Supplemental data

Journal Articles

A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data

Ti-Cheng Chang, Kelly M. Haupfear, Jing Yu, Evadnie Rampersaud, Vivien A. Sheehan, Jonathan M. Flanagan, Jane S. Hankins, Mitchell J. Weiss, Gang Wu, Sunitha Vege, Connie M. Westhoff, Stella T. Chou, Yan Zheng

Blood Adv (2020) 4 (18): 4347–4357.

https://doi.org/10.1182/bloodadvances.2020002148

Published: 2020

Includes: Supplemental data

Journal Articles

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Alexander Ngwube, Niketa Shah, Kamar Godder, David Jacobsohn, Monica L. Hulbert, Shalini Shenoy

Blood Adv (2020) 4 (16): 3894–3899.

https://doi.org/10.1182/bloodadvances.2020002236

Published: 2020

Journal Articles

Medical marijuana certification for patients with sickle cell disease: a report of a single center experience

Susanna A. Curtis, Dana Lew, Jonathan Spodick, Jeanne E. Hendrickson, Caterina P. Minniti, John D. Roberts

Blood Adv (2020) 4 (16): 3814–3821.

https://doi.org/10.1182/bloodadvances.2020002325

Published: 2020

Includes: Supplemental data

Journal Articles

Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects

Julie Kanter, Wally R. Smith, Payal C. Desai, Marsha Treadwell, Biree Andemariam, Jane Little, Diane Nugent, Susan Claster, Deepa G. Manwani, Judith Baker, John J. Strouse, Ifeyinwa Osunkwo, Rosalyn W. Stewart, Allison King, Lisa M. Shook, John D. Roberts, Sophie Lanzkron

Blood Adv (2020) 4 (16): 3804–3813.

https://doi.org/10.1182/bloodadvances.2020001743

Published: 2020

Journal Articles

Red blood cell adhesion to ICAM-1 is mediated by fibrinogen and is associated with right-to-left shunts in sickle cell disease

Erdem Kucukal, Yuncheng Man, Erina Quinn, Neil Tewari, Ran An, Anton Ilich, Nigel S. Key, Jane A. Little, Umut A. Gurkan

Blood Adv (2020) 4 (15): 3688–3698.

https://doi.org/10.1182/bloodadvances.2020001656

Published: 2020

Includes: Supplemental data

Journal Articles

Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?

Marilyn J. Telen

Blood Adv (2020) 4 (14): 3457–3465.

https://doi.org/10.1182/bloodadvances.2020001469

Published: 2020

Journal Articles

Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia

Xu Zhang, Kiarri N. Kershaw, Caterina P. Minniti, Andrew Campbell, Sohail R. Rana, Deepika S. Darbari, Lori Luchtman-Jones, Craig Sable, Niti Dham, Gregory Ensing, Manuel Arteta, James G. Taylor, VI, Lewis L. Hsu, Sergei Nekhai, Victor R. Gordeuk

Blood Adv (2020) 4 (14): 3311–3314.

https://doi.org/10.1182/bloodadvances.2020002077

Published: 2020

Journal Articles

Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease

Ibrahim M. Idris, Akib Abba, Jamil A. Galadanci, Sharfuddeen A. Mashi, Nafiu Hussaini, Sagir Ahmed Gumel, Arthur L. Burnett, Michael R. DeBaun

Blood Adv (2020) 4 (14): 3277–3283.

https://doi.org/10.1182/bloodadvances.2020002062

Published: 2020

Includes: Supplemental data

Journal Articles

Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease

Matthew M. Hsieh, Melissa Bonner, Francis John Pierciey, Jr, Naoya Uchida, James Rottman, Laura Demopoulos, Manfred Schmidt, Julie Kanter, Mark C. Walters, Alexis A. Thompson, Mohammed Asmal, John F. Tisdale

Blood Adv (2020) 4 (9): 2058–2063.

https://doi.org/10.1182/bloodadvances.2019001330

Published: 2020

Journal Articles

Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease

Andrew Srisuwananukorn, Rasha Raslan, Xu Zhang, Binal N. Shah, Jin Han, Michel Gowhari, Robert E. Molokie, Victor R. Gordeuk, Santosh L. Saraf

Blood Adv (2020) 4 (9): 1978–1986.

https://doi.org/10.1182/bloodadvances.2019001384

Published: 2020

Includes: Supplemental data

NARROW

Impact of a grant program to spur advances in sickle cell disease research

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease

Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage

Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease

FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice

Characterization and statistical modeling of glycosylation changes in sickle cell disease

MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease

Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Medical marijuana certification for patients with sickle cell disease: a report of a single center experience

Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects

Red blood cell adhesion to ICAM-1 is mediated by fibrinogen and is associated with right-to-left shunts in sickle cell disease

Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?

Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia

Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease

Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease

Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only